Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: Controlled longitudinal study

BMJ

Volumn 337, Issue 7669, 2008, Pages 557-560

  Law, Michael R ^a   Majumdar, Sumit R ^b   Soumerai, Stephen B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; MOMETASONE FUROATE; TEGASEROD; IMMUNOGLOBULIN G; INDOLE DERIVATIVE; PREGNANE DERIVATIVE; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANADA; DRUG MARKETING; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; ADVERTIZING; DRUG APPROVAL; DRUG COST; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; LONGITUDINAL STUDY; METHODOLOGY; STATISTICS; UNITED STATES;

ADVERTISING AS TOPIC; CANADA; DRUG APPROVAL; DRUG COSTS; HUMANS; IMMUNOGLOBULIN G; INDOLES; LONGITUDINAL STUDIES; MARKETING OF HEALTH SERVICES; PREGNADIENEDIOLS; PRESCRIPTIONS, DRUG; RECEPTORS, TUMOR NECROSIS FACTOR; UNITED STATES;

EID: 51949095234     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a1055     Document Type: Article

References (14)

1. Holmer AF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA 1999;281:380-2.
2. Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005;293:2030-3.
3. Mansfield PR. Do advertisements in clinical software influence prescribing? Med J Aust 2008;188:13-4.
4. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 2005;14:246-50.
5. Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003;169:405.
6. Centers for Medicare and Medicaid Services. State drug utilization data. Baltimore, MD: Centers for Medicare and Medicaid Services, 2007.
7. Centers for Medicare and Medicaid Services. Medicaid managed care enrollment report. Baltimore, MD: Centers for Medicare and Medicaid Services, 2005.
8. Shuchman M. Drug risks and free speech: can Congress ban consumer drug ads? N Engl J Med 2007;356:2236-9.
9. New York American Marketing Association. Effie awards brief of effectiveness: Zelnorm "Tummies". 2005. http://s3.amazonaws.com/ effie_assets/2005/573/2005_573_pdf_1.pdf.
10. Statistics Canada. Language composition of Canada: highlight tables, 2001 census. http://www12.statcan.ca/english/census01/products/highlight/ LanguageComposition/Page.cfm?Lang=E&Geo=PR&View=1a&Table= 1a&StartRec=1&Sort=2&B1==PR&View=1a&Table=1a&StartRec= 1&Sort=2&B1=Counts&B2=Both.
11. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
12. IAG Research. Advertising for prescription drugs is memorable and motivating: latest rankings for Rx Ads on television released by IAG Research. 2005. www.iagr.net/ne_press/pr_112905.jsp.
13. IAG Research. Prescription drug advertising break-through: IAG Research reveals the best prescription drug advertising from this past TV season. 2006. www.iagr.net/ne_press/pr_112906.jsp.
14. Applied Management. Canadians' access to insurance for prescription medicines. 2000. www.hc-sc.gc.ca/hcs-sss/pharma/acces/pubs_e.html.